TERT-BUTYL (R)-4-((R)-(2,3-DIHYDROBENZO(B)(1,4)DIOXIN-6-YL)(HYDROXY)METHYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE
UNII 8PM2RN776J
Substance Identification & Data
This profile provides standardized clinical and technical data for Tert-butyl (r)-4-((r)-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)(hydroxy)methyl)-2,2-dimethyloxazolidine-3-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8PM2RN776J.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 502483-53-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H27NO6 AHKQWNJYBALFQN-CZUORRHYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Tert-butyl (r)-4-((r)-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)(hydroxy)methyl)-2,2-dimethyloxazolidine-3-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.